Innovations in Obesity and Metabolic Technologies
Onciomed, Inc. has developed a novel, patented, minimally-invasive, reversible, technology for the treatment of the ongoing, worldwide epidemic of obesity and diabetes. The US spends over $147 B in obesity and related problems. CDC describes obesity as #1 preventable cause of death in United States. It use to be smoking. Onciomed, Inc is fulfilling the unmet clinical need.